• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Propeller Health

FDA clears Propeller Health sensor to work with Symbocort inhaler

May 27, 2020 By Sean Whooley

Propeller Health updated logo

Propeller Health announced that it received FDA 510(k) clearance for connecting patients using its Symbicort Inhaler to its digital health platform. The Madison, Wis.-based company’s digital health platform already connects to inhalers used by asthma and COPD patients, including ones manufactured by Boehringer Ingelheim, GlaxoSmithKline, Novartis and Orion, along with other generic equivalents. Get the full […]

Filed Under: Drug-Device Combinations, Featured, Respiratory Tagged With: Propeller Health

Propeller Health offers access to CVS, other pharmacies with Propeller app

November 19, 2019 By Sean Whooley

Propeller Health updated logo

Propeller Health announced today that users of its Propeller app are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly through that app. The Madison, Wis.–based company launched the app in January 2019, giving Walgreens patients the option to manage their asthma or chronic obstructive pulmonary disease medication regimen within the mobile app. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Respiratory Tagged With: Propeller Health

Propeller Health study suggests 84% of asthma inhaler use performed incorrectly

February 21, 2019 By Fink Densford

ResMed, Propeller Health

ResMed (NYSE:RMD) subsidiary Propeller Health today released results from a new study exploring real-world use of asthma rescue and controller inhalers that indicated that the majority of users did not use their inhalers properly. Results from the research were published in The Journal of Allergy and Clinical Immunology: In Practice, the Madison, Wisc.-based company said. Data in the study […]

Filed Under: Clinical Trials, Featured, Respiratory Tagged With: Propeller Health, ResMed

Propeller, Orion to develop digital asthma, COPD therapy

February 11, 2019 By Sarah Faulkner

Propeller Health updated logo

Propeller Health said today that it inked a deal to connect Orion’s Easyhaler line of inhalers for asthma and COPD with Propeller’s digital medicine platform. The two companies plan to co-develop a sensor that will attach to Orion’s inhalers and pair with a mobile app. Propeller touted that its existing digital medicine portfolio includes more […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: orion, Propeller Health, ResMed

Propeller Health launches in-app pharmacy feature

January 9, 2019 By Sarah Faulkner

Propeller Health My Pharmacy feature

Propeller Health today launched a feature within the Propeller mobile app designed to connect users directly with pharmacy services. The Madison, Wis.-based company kicked off the feature with Walgreens, giving Walgreens patients the option to manage their asthma or chronic obstructive pulmonary disease medication regimen within the mobile app. Using the My Pharmacy feature, people will […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals, Respiratory Tagged With: Propeller Health

ResMed closes $225m Propeller Health purchase

January 8, 2019 By Sarah Faulkner

ResMed, Propeller Health

ResMed (NYSE:RMD) said yesterday that it completed its $225 million acquisition of Propeller Health and its digital medicine platform. Lead by CEO David Van Sickle, Propeller will continue to operate as a standalone business within ResMed’s respiratory care portfolio, the companies reported. ResMed first announced the deal in December, explaining that Propeller’s products for people with […]

Filed Under: Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Propeller Health, ResMed

ResMed puts $225m on the table for Propeller Health

December 3, 2018 By Sarah Faulkner

ResMed, Propeller Health

ResMed (NYSE:RMD) said today that it inked a deal to acquire Propeller Health and its digital medicine platform for $225 million in cash. Propeller Health, which sells small sensors that attach to inhalers and track medication use, will operate as a standalone business under ResMed’s respiratory care portfolio. ResMed reported that Propeller’s products for people […]

Filed Under: Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Propeller Health, ResMed

Propeller Health touts link between air pollution, rescue inhaler use in nationwide asthma study

November 27, 2018 By Fink Densford

Propeller Health

Propeller Health today touted results from a nationwide study that indicated a direct association between daily air pollution and rescue inhaler use. Results from the study, which spanned five years and involved more than 2,800 individuals with asthma, were published in the Proceedings of the National Academy of Sciences, the Madison, Wisc.-based company said. Researchers in […]

Filed Under: Clinical Trials, Featured, Patient Monitoring, Respiratory Tagged With: Propeller Health

Propeller Health touts investment from McKesson Ventures

June 11, 2018 By Sarah Faulkner

Propeller Health

Building on a $20 million funding round announced last month, Propeller Health said today that it landed an investment of an undisclosed amount from McKesson Ventures. The company is looking to expand its digital therapeutics business beyond devices that manage the treatment of chronic respiratory diseases. Propeller noted that it’s interested in exploring opportunities in […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals Tagged With: aptarpharma, Propeller Health

Propeller raises $20m and prepares to extend reach beyond digital inhalers

May 31, 2018 By Sarah Faulkner

Propeller Health

Digital therapeutics company Propeller Health and drug-delivery device-maker Aptar Pharma are teaming up, yet again, to develop an array of connected drug-delivery devices. The pair has worked together in the past – in 2016, the companies launched the world’s first fully-integrated connected metered dose inhaler. Now, they hope to create a platform of digital therapeutics, […]

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Respiratory Tagged With: aptarpharma, Propeller Health

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS